NEUROENDOCRINE CANCER OF THE PROSTATE METASTATIC

NEUROENDOCRINE CANCER OF THE PROSTATE METASTATIC was reported 13 times

NEUROENDOCRINE CANCER OF THE PROSTATE METASTATIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Microtubule Inhibitor [EPC] 1 0.0000
1 Corticosteroid [EPC] 1 0.0000